Markets:

Overview

News

Currencies

International

Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

7.455 -0.035 (-0.47%)

Streaming Delayed Price Updated: 11:33 AM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities

March 19, 2025

Via ACCESS Newswire

Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes

March 19, 2025

Via ACCESS Newswire

Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

March 18, 2025

Via Benzinga

Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan

March 14, 2025

Via ACCESS Newswire

Bausch Health Announces Fourth Quarter and Full-Year 2024 Results

February 19, 2025

Via ACCESS Newswire

Earnings Scheduled For February 19, 2025 ↗

February 19, 2025

Via Benzinga

Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program

February 10, 2025

Via ACCESS Newswire

Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday ↗

February 20, 2025

Via Benzinga

Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises ↗

February 19, 2025

The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China.

Via Stocktwits

Topics Earnings

Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance ↗

February 19, 2025

Bausch Health Companies reported its fourth-quarter results after Wednesday's closing bell. Here's a look at the details from the report:

Via Benzinga

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

February 14, 2025

Via ACCESS Newswire

Bausch Health Provides Update on Strategic Alternatives

February 06, 2025

Via ACCESS Newswire

Bausch Health Announces Third Quarter 2024 Results

October 30, 2024

Via ACCESSWIRE

Tesla, Nvidia, GM And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

February 03, 2025

Via Benzinga

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

January 23, 2025

Via ACCESS Newswire

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program

January 17, 2025

Via ACCESS Newswire

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb

December 12, 2024

Via ACCESSWIRE

Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt ↗

December 07, 2024

Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.

Via Benzinga

Topics Supply Chain

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day

December 05, 2024

Via ACCESSWIRE

Bausch Health Appoints New Chief Medical Officer and Head of R&D

December 02, 2024

Via ACCESSWIRE

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

November 18, 2024

Via ACCESSWIRE

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS

November 18, 2024

Via ACCESSWIRE

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗

November 01, 2024

Via Benzinga

ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence

October 27, 2024

Via ACCESSWIRE

Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt ↗

October 26, 2024

IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders.

Via Benzinga

Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags ↗

October 21, 2024

S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day.

Via Benzinga

Topics Bankruptcy Stocks

Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces ↗

October 14, 2024

Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb.

Via Benzinga

Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024

October 09, 2024

Via ACCESSWIRE

Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises

October 08, 2024

Via ACCESSWIRE

Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

September 25, 2024

The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.

Via MarketBeat

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.